Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  2. The incomplete story of complete mesocolic excision - Authors' reply

    Publikation: Bidrag til tidsskriftLetterForskning

  3. 5-year outcome after complete mesocolic excision for right-sided colon cancer: a population-based cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Access to radiotherapy among circumpolar Inuit populations

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  • Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium
Vis graf over relationer

Patient-reported outcomes (PROs), such as symptoms, function, and other health-related quality-of-life aspects, are increasingly evaluated in cancer randomised controlled trials (RCTs) to provide information about treatment risks, benefits, and tolerability. However, expert opinion and critical review of the literature showed no consensus on optimal methods of PRO analysis in cancer RCTs, hindering interpretation of results. The Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium was formed to establish PRO analysis recommendations. Four issues were prioritised: developing a taxonomy of research objectives that can be matched with appropriate statistical methods, identifying appropriate statistical methods for PRO analysis, standardising statistical terminology related to missing data, and determining appropriate ways to manage missing data. This Policy Review presents recommendations for PRO analysis developed through critical literature reviews and a structured collaborative process with diverse international stakeholders, which provides a foundation for endorsement; ongoing developments of these recommendations are also discussed.

TidsskriftLancet Oncology
Udgave nummer2
Sider (fra-til)e83-e96
Antal sider14
StatusUdgivet - feb. 2020

Bibliografisk note

Copyright © 2020 Elsevier Ltd. All rights reserved.

ID: 59912774